Work

Alemtuzumab Induction in Lung Transplantation: Time to Move On?

Year: 2014

Type: editorial

Abstract: This editorial puts into perspective the findings of the first randomized, controlled trial examining alemtuzumab induction for lung transplantation, and highlights the challenges encountered with alemtuzumab induction in other solid organs. See article by Jaksch et al on page 1839.

Source: American Journal of Transplantation

DOI: 10.1111/ajt.12825

Authors: J.L. Todd, S.M. Palmer

Institutions: Duke University, Duke Medical Center, Duke Clinical Research Institute

Language: English

Topic: Transplantation: Methods and Outcomes

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,300

OpenAlex ID: W2147815491

Cites: 8

Cited by: 3

Related to: 10